The Discounted Cash Flow (DCF) valuation of Fennec Pharmaceuticals Inc (FENC) is (6.32) USD. With the latest stock price at 6.42 USD, the upside of Fennec Pharmaceuticals Inc based on DCF is -198.4%.
Based on the latest price of 6.42 USD and our DCF valuation, Fennec Pharmaceuticals Inc (FENC) is a sell. selling FENC stocks now will result in a potential gain of 198.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 7.1% | 6.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (36.71) - (3.52) | (6.32) |
| Upside | -671.9% - -154.8% | -198.4% |